Published in Biomed Res Int on June 22, 2015
Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol (2002) 3.20
Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science (2005) 2.31
Proceedings of the IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8. Lyon, France, 17-24 June 1997. IARC Monogr Eval Carcinog Risks Hum (1997) 2.28
Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer (2008) 2.24
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs (2007) 1.76
The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation (1996) 1.75
Long-term follow-up of patients with primary immunodeficiencies. J Allergy Clin Immunol (2007) 1.45
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation (2003) 1.14
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009. Eur J Cancer (2012) 1.12
Tumors of the immunocompromised patient. Annu Rev Med (1988) 1.08
Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant (2007) 1.08
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis (2003) 1.06
Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06
Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study. Am J Transplant (2012) 1.03
Incidence of breast cancer in Italy: mastectomies and quadrantectomies performed between 2000 and 2005. J Exp Clin Cancer Res (2009) 1.02
Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am (1993) 1.01
Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc (2001) 1.00
Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol (2010) 0.98
Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer (2005) 0.95
Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94
Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther (2013) 0.89
De novo malignancies after organ transplantation: focus on viral infections. Curr Mol Med (2013) 0.89
Update on the long-term complications of renal transplantation. Br Med Bull (2013) 0.89
Present and future of immunosuppressive therapy in kidney transplantation. Transplant Proc (2011) 0.88
New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando) (2012) 0.88
Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation (2007) 0.88
Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy. Transpl Infect Dis (2012) 0.86
Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transpl Int (2007) 0.86
Extrapleural solitary fibrous tumor: a clinicopathologic study of 19 cases. Int J Surg Pathol (2009) 0.86
Stop-flow technique for loco-regional delivery of high dose chemotherapy in the treatment of advanced pelvic cancers. Eur J Surg Oncol (2004) 0.85
Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening. Adv Chronic Kidney Dis (2014) 0.84
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapy. Trans Am Clin Climatol Assoc (2009) 0.83
European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.1. Organization of follow-up of transplant patients after the first year. Nephrol Dial Transplant (2002) 0.83
Wound complications after kidney transplantation in nondiabetic patients. Transplant Proc (2009) 0.83
Difficult vascular conditions in kidney transplantation. Transplant Proc (2006) 0.81
Phase I/II study of paclitaxel and vinorelbine in metastatic breast cancer. Breast Cancer Res Treat (1998) 0.81
Organ transplantation and malignancy: inevitable linkage. Transplant Proc (2002) 0.80
Healing of surgical incision in kidney transplantation: a single transplant center's experience. Transplant Proc (2006) 0.77
Older kidneys donor transplantation: five years' experience without biopsy and using clinical laboratory and macroscopic anatomy evaluation. Transplant Proc (2007) 0.77
Suboptimal kidney: the experience of a single transplant unit. Transplant Proc (2004) 0.76
Pitfalls in diagnostic imaging of cystic pancreatic masses: a case of true cystic lesion mimicking a mucinous cystadenoma. JOP (2012) 0.76
Rare multiple primary malignancies among surgical patients-a single surgical unit experience. Ecancermedicalscience (2014) 0.76
Multiple unrelated malignancies following renal transplantation: an evaluation of four cases. Intern Med (2013) 0.76
Incidence of second primary cancer in transplanted patients. Transplantation (2006) 0.76